nach oben

Erschienen in:

01.08.2009 | Original Paper

Effects of UVA irradiation following treatment with 8-methoxypsoralen on type I and type III collagen synthesis in normal and scleroderma fibroblast cultures

verfasst von: Yohei Kitamura, Hiromi Namikawa, Shujiro Hayashi, Takahiro Yoshida, Toshihiro Suzuki, Yoichiro Hamasaki, Soji Yamazaki, Atsushi Hatamochi

Erschienen in: Archives of Dermatological Research | Ausgabe 7/2009

Einloggen, um Zugang zu erhalten

Abstract

Recent studies have demonstrated the efficacy of PUVA (psoralen plus ultraviolet A irradiation) therapy against sclerotic skin lesions in scleroderma, although the mechanisms underlying the improvement of the skin sclerosis by this therapy remain unknown. We investigated the effects of ultraviolet A (UVA) irradiation following the treatment with 8-methoxypsoralen on types I and III collagen synthesis and the gene expression of collagenase in cultured normal and scleroderma fibroblasts. The treatment reduced types I and III collagen synthesis and consequently, the types I and III collagen mRNA levels, in a UVA dose-dependent manner in both the normal and SSc fibroblasts, whereas the mRNA levels of collagenase remained almost unaltered. These results suggest that reduction of collagen synthesis by the fibroblasts may be one of the mechanisms underlying the efficacy of PUVA therapy against the sclerotic skin lesions in scleroderma.

Angel P, Pöting A, Mallick U, Rahmsdorf HJ, Schorpp M, Herrlich P (1986) Induction of metallothionein and other mRNA species by carcinogens and tumor promoters in primary human skin fibroblasts. Mol Cell Biol 6:1760–1766PubMed

Arcari P, Martinelli R, Salvatore F (1984) The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: evidence for multiple mRNA species. Nucl Acids Res 12:9179–9189. doi:10.1093/nar/12.23.9179 PubMedCrossRef

Besaratinia A, Pfeifer GP (2004) Biological consequences of 8-methxypsoralen-photoinduced lesions: sequence-specificity of mutations and preponderance of T to C and T to A mutations. J Invest Dermatol 123:1140–1146. doi:10.1111/j.0022-202X.2004.23502.x PubMedCrossRef

Black CM, Silman AJ, Herrick AI, Denton CP, Wilson H, Newman J, Pompon L, Shi-Wen X (1999) Interferon-α does not improve outcome at One year in patients with diffuse cutaneous scleroderma:results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 42:299–305. doi:10.1002/1529-0131(199902)42:2<299::AID-ANR12>3.0.CO;2-R PubMedCrossRef

Chu ML, Myers JC, Bernard MP, Ding JF, Ramirez F (1982) Cloning and characterization of five overlapping cDNAs specific for the human pro alpha 1(I) collagen chain. Nucleic Acids Res 10:5925–5934. doi:10.1093/nar/10.19.5925 PubMedCrossRef

Chu M-L, Mann K, Deutzmann R, Pribula Conway D, Hsu-Chen CC, Bernard MP, Timpl R (1987) Characterization of three constituent chains of collagen type VI by peptide sequences and cDNA clones. Eur J Biochem 168:309–317. doi:10.1111/j.1432-1033.1987.tb13422.x PubMedCrossRef

Clements PJ, Furst DE, Wong WK, Mayes M, White B, Wigley F, Weisman MD, Barr W, Moreland L, Medsger TA Jr, Steen V, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Wong WK (1999) High-dose versus low-dose d-penicillamine in early diffuse systemic sclerosis:anaiysis of a two-year, double-blind, randomized, controlled clinical trial. Arthritis Rheum 42:1194–1203. doi:10.1002/1529-0131(199906)42:6<1194::AID-ANR16>3.0.CO;2-7 PubMedCrossRef

Denton CP, Merkel A, Furst DE, Khanna D, Emery P, Hsu VM, Silliman N, Streisand J, Powell J, Akesson A, Coppock J, Hoogen F, Herrick A, Mayes MD, Veale D, Haas J, Ledbetter S, Korn JH, Black CM, Seibold JR, Cat-192 Study Group; Scleroderma Clinical Trials Consortium (2007) Recombinant human anti-transforming growth factor beta 1 antibody therapy in systemic scierosis: a multicenter, randomized, placebocontrolled phase I/II trial of CAT-192. Arthritis Rheum 56:323–333. doi:10.1002/art.22289

de Wet W, Bernard M, Benson-Chanda V, Chu ML, Dickson L, Weil D, Ramirez F (1987) Organization of the human pro-α2(I) collagen gene. J Biol Chem 262:16032–16036PubMed

10.

Fleischmajer R, Perlish JS, Krieg T, Timple R (1981) Variability in collagen and fibronectin synthesis by scleroderma fibroblasts in primary culture. J Invest Dermatol 76:400–403. doi:10.1111/1523-1747.ep12520933 PubMedCrossRef

11.

Hashikabe M, Ohtsuka T, Yamazaki S (2005) Quantitative echographic analysis of photochemotheray on systemic sclerosis skin. Arch Dermatol Res 296:522–527. doi:10.1007/s00403-005-0552-1 PubMedCrossRef

12.

Hatamochi A, Aumailley M, Mauch C, Chu M-L, Timpl R, Krieg T (1989) Regulation of collagen VI expression in fibroblasts Effects of cell density, cell-matrix interactions, and chemical transformation. J Biol Chem 264:3494–3499PubMed

13.

Heckmann M, Aumailley M, Hatamochi A, Chu M-L, Timpl R, Krieg T (1989) Down-regulation of alpha 3(VI) chain expression by gamma- interferon decreases synthesis and deposition of collagen type VI. Eur J Biochem 182:719–726. doi:10.1111/j.1432-1033.1989.tb14884.x PubMedCrossRef

14.

Herrmann G, Brenneisen P, Wlaschek M, Wenk J, Faisst K, Quel G, Hommel C, Goerz H, Goerz G, Ruzicka T, Thomas R, Krieg T, Sies H, Scharffetter-Kochanek K (1998) Psoralen photoactivation promotes morphological and functional changes in fibroblasts in vitro reminiscent of cellular senescence. J Cell Sci 111:759–767PubMed

15.

Jander R, Rauterberg J, Glanville RW (1983) Further characterization of the three polypeptide chains of bovine and human short-chain collagen (intima collagen). Eur J Biochem 133:39–46. doi:10.1111/j.1432-1033.1983.tb07427.x PubMedCrossRef

16.

Jimenez SA, Hitraya E, Varga J (1996) Pathogenesis of scleroderma collagen. Rheum Dis Clin North Am 22:647–674. doi:10.1016/S0889-857X(05)70294-5 PubMedCrossRef

17.

Kerscher M, Volkenandt M, Meurer M, Lehmann P, Plewig G, Röchen M (1994) Treatment of localized scleroderma with PUVA bath photochemotherapy. Lancet 343:1233. doi:10.1016/S0140-6736(94)92449-X

18.

Kerscher M, Dirschka T, Volknandt M (1995) Treatment of localized scleroderma by PUVA phototheraoy. Lancet 346:1166. doi:10.1016/S0140-6736(95)91843-4

19.

Kanekura T, Fukumaru S, Matsushita S, Terasaki K, Mizoguchi S, Kanzaki T (1996) Successful treatmet of scleroderma with PUVA therapy. J Dermatol 23:455–459PubMed

20.

Liau G, Yamada Y, de Crombrugghe B (1985) Coordinate regulation of the levels of type III and type I collagen mRNA in most but not all mouse fibroblasts. J Biol Chem 260:531–536PubMed

21.

Lichtenstein JR, Byers PH, Smith BD, Martin GR (1975) Identification of the collagenous proteins synthesized by cultured cells from human skin. Biochemistry 22:1589–1594. doi:10.1021/bi00679a007 CrossRef

22.

Miskulin M, Dalgleish R, Kluve-Beckerman B, Rennard SI, Tolstoshev P, Brantly M, Crystal RG (1986) Human type III collagen gene expression is coordinately modulated with the type I collagen genes during fibroblast growth. Biochemistry 25:1408–1413. doi:10.1021/bi00354a033 PubMedCrossRef

23.

Mori K, Hatamochi A, Ueki H, Olsen A, Jimenez SA (1996) The transcription of humanα1(I)procollagen gene(COL 1 A 1) is suppressed by tumor necrosis factor-αthrough proximal short promoter elements-evidence for suppression mechanisms mediated by two nuclear factor binding sites. Biochem J 319:811–816PubMed

24.

Morita A, Sakakibara S, Skakibara N, Yamauchi R, Tsuji T (1995) Successful treatment of systemic sclerosis with topical PUVA. J Rheumatol 22:2361–2365PubMed

25.

Olsen D, Peltonen J, Jaakkola S, Chu M-L, Uitto J (1989) Collagen gene expression by human skin fibroblasts: abundant steady-state levels of type VI procollagen mRNAs. J Clin Invest 183:791–795. doi:10.1172/JCI113959 CrossRef

26.

Parker ML, Judge K, Gevers W (1982) Loss of type I procollagen gene expression in SV40-transformed human fibroblasts is accompanied by hypermethylation of these genes. Nucleic Acids Res 10:5879–5891. doi:10.1093/nar/10.19.5879 PubMedCrossRef

27.

Polisson RP, Gilkeson GS, Pyun EH, Pisetsky DS, Smith EA, Simon LS (1996) A multicenter trial of recombinant human interferon γ in patients with systemi sclerosis:effects on cutaneous fibrosis and interleukin 2 receptor levels. J Rheumatol 23:654–658PubMed

28.

Saitta B, Gaidarova S, Cicchillitti L, Jimenez SA (2000) CCAAT binding transcription factor binds and regulates human COL1A1 promoter activity in human dermal fibroblasts: demonstration of increased binding in systemic sclerosis fibroblasts. Arthritis Rheum 43:2219–2229. doi:10.1002/1529-0131(200010)43:10<2219::AID-ANR9>3.0.CO;2-N PubMedCrossRef

29.

Sato M, Shegogue D, Hatamochi A, Yamazaki S, Trojanowska M (2004) Lysophosphatidic acid inhibits TGF-beta-mediated stimulation of type I collagen mRNA stability via an ERK-dependent pathway in dermal fibroblasts. Matrix Biol 23:353–361. doi:10.1016/j.matbio.2004.07.005 PubMedCrossRef

30.

Scharffetter K, Wlaschek M, Hoog A, Bolsen K, Schothorst A, Goerz G, Krieg T, Plewig G (1991) UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo. Arch Dermatol Res 283:506–511. doi:10.1007/BF00371923 PubMedCrossRef

31.

Scharffetter-Kochanek K, Goldermann R, Lehmann P, Hölzle E, Goerz G (1995) PUVA therapy in disabling pansclerotic morphoea of children. Br J Dermatol 132(5):830–831PubMedCrossRef

32.

Seibold JR, Korn JH, Simms R, Clements PJ, Moreland LW, Mayes MD, Furst DE, Rothfield N, Steen V, Weisman M, Collier D, Wigley FM, Merkel PA, Csuka ME, Hsu V, Rocco S, Erikson M, Hannign J, Harkonen WS, Sanders ME (2000) Recombinant human relaxin in the treatment of scleroderma: a randomized, double, placebo-controlled trial. Ann Intern Med 132:871–879PubMed

33.

Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic, Therapeutic Criteria Committee (1980) Preliminary criteria for theclassification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590. doi:10.1002/art.1780230510 CrossRef

34.

Trueb B, Winterhalter K (1986) Type IV collagen is composed of a 200 kd subunit and two 140 kd subunit. EMBO J 5:2815–2819PubMed

Titel: Effects of UVA irradiation following treatment with 8-methoxypsoralen on type I and type III collagen synthesis in normal and scleroderma fibroblast cultures
verfasst von: Yohei Kitamura
Hiromi Namikawa
Shujiro Hayashi
Takahiro Yoshida
Toshihiro Suzuki
Yoichiro Hamasaki
Soji Yamazaki
Atsushi Hatamochi
Publikationsdatum: 01.08.2009
Verlag: Springer-Verlag
Erschienen in: Archives of Dermatological Research / Ausgabe 7/2009
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI: https://doi.org/10.1007/s00403-009-0949-3

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Dermatologie

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

16.04.2024 DGIM 2024 Nachrichten

Den Reflex, eine oberflächliche chronische Hautwunde ohne Entzündungszeichen in jedem Fall abzustreichen, sollte man nach einer neuen „Klug-entscheiden“-Empfehlung unterdrücken.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2009

Both all-trans retinoic acid and cytochrome P450 (CYP26) inhibitors affect the expression of vitamin A metabolizing enzymes and retinoid biomarkers in organotypic epidermis

Activation of peroxisome proliferator-activated receptor-γ inhibits transforming growth factor-β1 induction of connective tissue growth factor and extracellular matrix in hypertrophic scar fibroblasts in vitro

Exogenous N-acetylglucosamine increases hyaluronan production in cultured human dermal fibroblasts

Influence of a commercial tattoo ink on protein production in human fibroblasts

Beneficial regulation of matrixmetalloproteinases and their inhibitors, fibrillar collagens and transforming growth factor-β by Polypodium leucotomos, directly or in dermal fibroblasts, ultraviolet radiated fibroblasts, and melanoma cells